The IPO (Initial Public Offering) of Akums Drugs and Pharmaceuticals Ltd has ended, and investors are eagerly waiting for the share allotment, expected to be finalized today.
Key Dates:
- Bidding Period: July 30 to August 1
- Allotment Date: August 2
- Listing Date: August 6
How to Check Allotment Status:
- Visit the Link Intime India website: Link
- Select the company: Choose ‘Akums Drugs and Pharmaceuticals Limited’ from the dropdown menu.
- Choose your details: Select PAN, Application Number, DP/Client ID, or Account Number/IFSC.
- Enter your information: Fill in the details based on your chosen option.
Your allotment status will be shown on the screen.
IPO Details:
- Price Band: ₹646 to ₹679 per share
- Total Funds Raised: ₹1,856.74 crore (₹680 crore from fresh issue, ₹1,176.74 crore from offer for sale)
Current Grey Market Premium (GMP):
- GMP Today: ₹141 per share
- Trading Price in Grey Market: ₹820 per share (a 20.77% premium to the issue price of ₹679)
Subscription Status:
- Total Subscription: 63.56 times
- Retail Investors: 21.30 times
- Non-Institutional Investors: 42.21 times
- Qualified Institutional Buyers: 90.09 times
Company Overview:
Akums Drugs and Pharmaceuticals is a leading contract development and manufacturing organization (CDMO) offering a wide range of pharmaceutical products and services in India and abroad. They provide end-to-end product development and manufacturing solutions, and also manufacture and sell branded pharmaceutical formulations and active pharmaceutical ingredients.
Use of IPO Proceeds:
- Repayment or prepayment of company debt
- Funding working capital needs
- Pursuing growth through acquisitions
- General corporate purposes
Book running lead managers for this IPO are ICICI Securities, Axis Bank, Citigroup Global Markets India Private Limited, and Ambit Private Limited. The IPO registrar is Link Intime India Private Ltd.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
